Rigel Pharmaceuticals Inc (RIGL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RIGL Annual Balance Sheets →
A period-by-period view of the balance sheet from Rigel Pharmaceuticals Inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent95.39
Combined Cash+Investments Total (filer-reported)95.30
Short-term Investments, Total34.66
Short-term Investments95.30
Cash & Short-term Investments224.00
Accounts receivable56.04
Notes Receivable, Current0.30
Inventories14.37
Other Current Assets0.00
Prepaid Expense And Other Assets Current19.79
Total Current Assets185.53
Equipment/Property/Plant Net0.00
Intangible Assets93.88
Deferred, Prepaid and Other Assets, Noncurrent0.76
Other Assets, Noncurrent110.58
Total Assets521.07
Liabilities
Accounts Payable, Current AC4.01
Employee-related Liabilities, Current AC8.61
Loans Payable, Current NO39.24
Other Liabilities, Current0.00
Total Current Liabilities95.59
Long-term debt39.24
Total Long-term Debt39.24
Other liabilities, Noncurrent4.55
Total Liabilities95.64
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,422.65
Retained Earnings / Accumulated Deficit-997.10
Accumulated Other Comprehensive Income-0.15
Other Equity-0.15
Common Stockholder's Equity425.42
Total Stockholder's Equity425.42
Liabilities & Stockholder's Equity521.07
4 historic quarters locked

Sign in to unlock the full Rigel Pharmaceuticals Inc balance sheet history.

About Rigel Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001034842-26-000052

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.